GGrantIndex
Sort

21,281 grants matching influenza

Vaccine Induced Immunity in the Young and Aged

$2,976,722
Rafi Ahmed · Emory University · U19 · FY2013 · AI

NIAID Centers of Excellence for Influenza Research and Response (CEIRR): Universal Influenza Vaccine Research Activities

$2,973,488
Anice Lowen · Emory University · N01 · FY2025 · AI

Structure-function analysis of infection- and vaccine-induced B-cell repertoires

$2,972,315
Stephen C Harrison · Boston Children'S Hospital · P01 · FY2024 · AI

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

$2,969,015
David S Stephens · Emory University · UM1 · FY2022 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS

$2,968,370
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2019 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS

$2,967,125
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI

ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH

$2,962,803
Emily Gurley · International Ctr/Diarrhoeal Dis Res · U01 · FY2014 · GH

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$2,959,515
Richard Rothman · Johns Hopkins University · N01 · FY2014 · AI

Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

$2,955,452
Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Cellular Immunity to Category A-C Viruses in Humans

$2,955,191
Robert William Finberg · Univ Of Massachusetts Med Sch Worcester · U19 · FY2013 · AI

Advanced Development of Vaccines for Infectious Diseases

$2,955,109
Uwe Staerz · Greffex, Inc. · N01 · FY2020 · AI

Systems Immune Profiling of Divergent Responses to Infection

$2,954,296
David A. Hafler · Yale University · U19 · FY2018 · AI

Structure-function analysis of infection- and vaccine-induced B-cell repertoires

$2,950,624
Stephen C Harrison · Boston Children'S Hospital · P01 · FY2025 · AI

CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations

$2,949,775
Ted Ross · University Of Georgia · N01 · FY2024 · AI

CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations

$2,949,775
Ted Ross · University Of Georgia · N01 · FY2024 · AI

CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations

$2,949,775
Ted Ross · University Of Georgia · N01 · FY2024 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$2,948,804
John Jay Treanor · University Of Rochester · N01 · FY2016 · AI

Manipulating natural host immunoregulation via IDO during viral Infection

$2,944,781
Andrew Lee Mellor · Augusta University · U01 · FY2010 · AI

Systems Biological Analysis of Innate and Adaptive Responses to Vaccination

$2,937,945
Bali Pulendran · Emory University · U19 · FY2013 · AI

Stony Brook University Laboratory for Comparative Medicine to Support Pandemic Preparedness

$2,933,079
David G Thanassi · State University New York Stony Brook · G20 · FY2022 · AI

Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus

$2,928,907
Mark M Davis · Stanford University · U19 · FY2010 · AI

GH16-006: Conducting Public Health Research in Kenya

$2,923,180
Christopher D Bayer · Hjf Medical Research International, Inc. · U01 · FY2018 · GH

MIDAS Center for Communicable Disease Dynamics

$2,914,212
Marc Lipsitch · Harvard School Of Public Health · U54 · FY2011 · GM

Vaccination and infection: indicators of immunological health and responsiveness

$2,908,842
Mark M Davis · Stanford University · U19 · FY2013 · AI

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS: CLINICAL CORE

$2,907,143
Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2021 · AI